Skip to main content
UKCRC Health Research Classification System

6.1 Pharmaceuticals

Main inclusion criteria

Clinical application and evaluation of pharmaceutical small molecules, therapeutic vaccines, antibodies and hormones in humans including:

  • small scale settings and pilot studies
  • phase I, II, III and IV trials
  • assessing sensitivity, efficacy, specificity, relapse, survival, therapeutic value, pharmacokinetics, reproducibility and safety
  • studies monitoring response, outcome, drug resistance and side effects


Advice on research activities

Includes studies of nutritional supplements used as treatments for disease.

Excludes studies focused on the potentially chemopreventative / health protective effects of specific nutrients, probiotics and nutritional supplements, which should be coded 3.3 Nutritional Prevention.

Official terminology

Full name of code

Short name Unique ID
6.1 Pharmaceuticals 6.1 Pharmaceutical



Related external links

Common Scientific Outline (CSO) – 5.4 Systemic Therapies – Clinical Applications